Ceradan Advanced is a patented next-generation emollient therapy for eczema-prone skin conditions. It is currently waiting for approval in 13 other countries including Singapore, Malaysia, China, and the US.
“The patent approval of Ceradan Advanced is an affirmation of our research‐based approach to product development. Patenting our Intellectual Property is strategic as it contributes towards the expansion of Ceradan Advanced’s branding,” says Lim See Wah, CEO of Hyphens Pharma.
